Press Releases

2016  |  2015  |  2014  |  2013


BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System


2016 Analyst Day Presentations


BD Announces 2016 Analyst Day and Webcast


BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery


BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin


BD Announces Results for 2016 Fourth Fiscal Quarter and Full Year


BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections


BD and Apax Partners Announce Closing of Joint Venture to Launch Global Respiratory Business


BD Expands Efforts to Combat Antimicrobial Resistance with New Automated ID/AST System


BD Receives FDA 510(k) Clearance for Innovative Next Generation Blood Collection and Separation Technology Designed to Improve Laboratory Efficiency


BD Invests $100 Million in Nebraska Plant to Expand Insulin Syringe Manufacturing


BD Unveils Next Generation Wireless Point-of-Care Diagnostic Device


BD and Vancive Medical Technologies Launch New Vascular Dressings with CHG Antimicrobial


BD Expands Portfolio of Reproductive and Sexually Transmitted Infections Solutions


BD Announces New Software Release for Pyxis Enterprise Solution


BD Submits Pre-Market Approval Application to FDA for BD Onclarity™ HPV Test


Mayo Clinic Proceedings Publishes New Insulin Injection and Infusion Recommendations


BD Cited as Infusion Pump EMR Integration Leader in Klas Report


BD Receives FDA Clearance for New Syringe Designed for the Administration of Humulin® R U-500 Insulin


BD Announces Results for 2016 Third Fiscal Quarter


BD Names R. Andrew Eckert To Board Of Directors


BD Board Declares Dividend


BD Hits Century Mark with Infusion Pump Interoperability


BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call


BD and Check-Points Announce Development and Global Distribution Agreement for BD MAX™ Assays that Detect Carbapenem—resistant Organisms


BD Expands its Portfolio of Easy-to-Use Cell Sorters with Introduction of BD FACSMelody™ System


BD Expands Reproductive and Sexually Transmitted Infections Portfolio with CE Mark for the BD MAX™ Vaginal Panel


BD Announces Results for 2016 Second Fiscal Quarter


BD Extends Longstanding Expertise in Diabetes Management to Benefit Pets


BD Introduces New Low-Temperature Sterilization Containers


BD Divests Vertebral Augmentation Solutions Business to Stryker


BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ PEDS Plus™/F Plastic Bottle


MedMined® Surveillance Advisor Wins 2015/2016 KLAS Category Leader Award


BD, Apax Partners to Form Joint Venture for Respiratory Solutions


BD Receives FDA Approval for New Automated Cervical Cancer Screening System


BD Utilizes AT&T Connectivity to Offer Connected Wireless Health Devices


BD Receives CE Mark for Next Generation Blood Separation Technology


Alaris™ System Named 2015 Best In KLAS for Smart Pumps


BD Receives FDA 510(k) Clearance for New Blood Collection Device to Help Enhance Patient and Clinician Experience


BD Unveils New Next Generation Sequencing Library Prep System at the 2016 Advances in Genome Biology and Technology Meeting


BD Launches BD FACSymphony™ High-Speed Cell Analyzer to Enable Identification and Analysis of Rare Cell Types


BD Licenses Technology to Advance Testing for Preeclampsia, Gestational Diabetes


BD Announces Results for 2016 First Fiscal Quarter


BD Board Declares Dividend


Singularity University and BD Announce Collaboration Dedicated to Address Global Healthcare Challenges


BD Announces Webcast of Annual Meeting of Shareholders


Fresenius Kabi USA Acquires U.S. Pharmaceutical Plant and Ready to Administer Drugs from BD


BD Divests BD RX Business, Adding IV Solutions


BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call


BD to Present at the 34th Annual J. P. Morgan Healthcare Conference